Open-label Safety Extension Study Assessing Safety and Tolerability of LAI in Patients Who Participated in Study INS-212

Clinical trial NCT02628600 · COMPLETED

Trial details

NCT number: NCT02628600
Sponsor: Insmed Incorporated
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

NTM Lung Infection Due to MAC

Start date: 2016-02-05
Primary completion: 2018-10-17
Enrollment: 163

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.